​

OnKure Therapeutics Ownership | Who Owns OnKure Therapeutics?

OverviewFinancialsChart

OnKure Therapeutics Ownership Summary

OnKure Therapeutics is owned by 5.29% institutional investors, 1.45% insiders, and 93.26% retail investors. Cormorant asset management, lp is the largest institutional shareholder, holding 13.69% of OKUR shares.

OKUR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOnKure Therapeutics5.29%1.45%93.26%
SectorHealthcare Stocks 278.45%10.60%-189.04%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Cormorant asset management, lp1.84M13.69%$7.90M
Perceptive advisors1.00M7.48%$4.32M
Samsara biocapital824.15K6.14%$3.54M
Vestal point capital, lp635.00K4.73%$2.73M
Deep track capital, lp523.99K3.90%$2.25M
Ikarian capital253.75K1.89%$1.09M
Prosight management, lp186.57K1.39%$802.25K
Nantahala capital management54.21K0.40%$233.09K
Adar1 capital management10.00K0.07%$43.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Samsara biocapital824.15K0.63%$3.54M
Cormorant asset management, lp1.84M0.59%$7.90M
Prosight management, lp186.57K0.26%$802.25K
Vestal point capital, lp635.00K0.20%$2.73M
Perceptive advisors1.00M0.15%$4.32M
Ikarian capital253.75K0.13%$1.09M
Deep track capital, lp523.99K0.07%$2.25M
Nantahala capital management54.21K0.01%$233.09K
Adar1 capital management10.00K0.01%$43.00K

Top Buyers

HolderShares% AssetsChange
Prosight management, lp186.57K0.26%122.82K
Adar1 capital management10.00K0.01%10.00K
Cormorant asset management, lp1.84M0.59%-
Ikarian capital253.75K0.13%-
Perceptive advisors1.00M0.15%-

Top Sellers

HolderShares% AssetsChange
Nantahala capital management54.21K0.01%-569.00
Samsara biocapital824.15K0.63%-
Cormorant asset management, lp1.84M0.59%-
Ikarian capital253.75K0.13%-
Perceptive advisors1.00M0.15%-

New Positions

HolderShares% AssetsChangeValue
Adar1 capital management10.00K0.01%10.00K$43.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20252-710,559-5-2---

Recent Insider Transactions

DateNameRoleActivityValue
Jun 23, 2025Saccomano Nicholas A President and CEOSell$209.81
Jun 23, 2025Leverone Jason A. Chief Financial OfficerSell$722.41
May 15, 2025Cormorant Asset Management, LP Former 10% OwnerSell$3.36M
May 15, 2025ACORN BIOVENTURES, L.P.-Buy$2.09M
May 15, 2025ACORN BIOVENTURES, L.P.-Buy$500.00K

Insider Transactions Trends

DateBuySell
2025 Q228
2025 Q1--
2024 Q4--

OKUR Ownership FAQ

Who Owns OnKure Therapeutics?

OnKure Therapeutics shareholders are primarily institutional investors at 5.29%, followed by 1.45% insiders and 93.26% retail investors. The average institutional ownership in OnKure Therapeutics's industry, Biotech Stocks , is 63.84%, which OnKure Therapeutics falls below.

Who owns the most shares of OnKure Therapeutics?

OnKure Therapeutics’s largest shareholders are Cormorant asset management, lp (1.84M shares, 13.69%), Perceptive advisors (1M shares, 7.48%), and Samsara biocapital (824.16K shares, 6.14%). Together, they hold 27.31% of OnKure Therapeutics’s total shares outstanding.

Does Blackrock own OnKure Therapeutics?

BlackRock is not among the top 10 institutional shareholders of OnKure Therapeutics.

Who is OnKure Therapeutics’s biggest shareholder by percentage of total assets invested?

Samsara biocapital is OnKure Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.63% of its assets in 824.16K OnKure Therapeutics shares, valued at 3.54M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools